Disease
Michele Banks: The Pulse of Life in Ink and Color
Michele Banks, known as Artologica, is a Washington, D.C.-based artist using watercolor and ink to explore themes such as cell division, neuroscience, the microbiome, and climate change. Her pieces capture a slightly abstracted scientific imagery, creating beautiful interpretations of biological and environmental processes.
Banks has exhibited her work at the National Institutes of Health (NIH), the American Association for the Advancement of Science (AAAS), and major scientific conferences, including the Society for Neuroscience and the American Society for Microbiology. Her art has appeared on journal covers, in textbooks, and in publications such as Scientific American, The Scientist, and Wired.
Dame Sarah Gilbert: The Scientist Who Helped Save Millions of Lives
Dame Sarah Gilbert, Born in April 1962, is a vaccinologist whose groundbreaking work on the Oxford AstraZeneca COVID-19 vaccine has saved millions of lives worldwide.
In 1983, Gilbert graduated with a Bachelor of Science in Biological Sciences from the University of East Anglia. She then pursued a PhD at the University of Hull, focusing her studies on the genetics and biochemistry of the yeast Rhodosporidium toruloides, and earned her doctorate in 1986.
Supercomputer Using AI to Develop Vaccines
A £225m supercomputer is using artificial intelligence (AI) to develop new drugs and vaccines.
When it is fully operational this summer, the Isambard-AI computer in Bristol will be the most powerful supercomputer in the UK.
Last week, Prime Minister Sir Keir Starmer unveiled plans to “unleash AI” across the UK in an effort to boost growth.
Simon McIntosh-Smith, a professor in high-performance computing at Bristol University, said the Isambard-AI meant the UK “genuinely can be competitive with the world”.
A Shining New Age of Vaccines
With vaccines, history repeats itself like music stuck in a loop. On the one hand, advancing technologies create vaccines against a growing list of lethal diseases and conditions. On the other hand, outrageous myths and conspiracy theories compete against science. Familiar and strong emotions run the gamut, from relief when deadly diseases like smallpox are eradicated to anger about perceived dangers to health, governmental overreach and threats to freedom of choice. While religious, commercial, pseudo-scientific and political interests cash in on the confusion, context and meaning are sometimes lost or forgotten. Telling facts apart from misinformation becomes difficult.
Understanding how vaccines are evolving can help better understand both why they are one of medical science’s supreme triumphs and also why the anti-vaccine movement continues to grow and influence so many.
Types of Vaccinations
This infographic from Boston University provides a side-by-side comparison of different types of vaccinations, showcasing their similarities and differences in how they trigger and support the body’s immune response.
Dr. Nora Volkow: The Brain Behind Modern Addiction Research
Dr. Nora Volkow, a distinguished neuroscientist, is an important contributor in the fields of addiction science and mental health research.
Born in Mexico City in 1956, Dr. Volkow demonstrated academic prowess from the start, attending the National University of Mexico’s Medical School, where she was awarded the prestigious Robins Award for being the best medical student of her generation. She attending New York University to further her expertise in psychiatry, earning a Laughlin Fellowship for being one of the ten most outstanding psychiatric residents in the United States.
More Teens than Ever are Overdosing
For years, students in middle and high schools across the country were urged to “just say no” to drugs and alcohol. But it’s no secret that the Drug Abuse Resistance Education (D.A.R.E.) program, which was typically delivered by police officers who urged total abstinence, didn’t work.
A meta-analysis found the program largely ineffective and one study even showed that kids who completed D.A.R.E. were more likely than their peers to take drugs (Ennett, S. T., et al., American Journal of Public Health, Vol. 84, No. 9, 1994; Rosenbaum, D. P., & Hanson, G. S., Journal of Research in Crime and Delinquency, Vol. 35, No. 4, 1998).
“We know that the ‘Just Say No’ campaign doesn’t work. It’s based in pure risks, and that doesn’t resonate with teens,” said developmental psychologist Bonnie Halpern-Felsher, PhD, a professor of pediatrics and founder and executive director of several substance use prevention and intervention curriculums at Stanford University. “There are real and perceived benefits to using drugs, as well as risks, such as coping with stress or liking the ‘high.’ If we only talk about the negatives, we lose our credibility.”
Terrifying Trends in Adolescent Substance Abuse
Globally, an estimated 64 million people were suffering from drug use disorders in 2022, with cases of adolescent substance abuse evident in all regions of the world.
Adolescence describes the phase of life when people transition from childhood to adulthood (ages 10-19). During this period a person experiences rapid biological, cognitive, physiological, and psychological change. It’s also when a person establishes both positive and negative patterns of behavior that can relate to physical activity, diet, sexual activity, and substance use. This vital stage of human development is crucial in building the foundations of good health as these learnt behaviors can continue to influence a person for the rest of their lives. When adolescents are continuously exposed to substances before their brain can fully mature there is a much higher risk of developing a dependency and psychiatric complications.
Creating Drug-Free Communities
The Drug-Free Communities (DFC) Support Program is administered by the White House Office of National Drug Control Policy (ONDCP) and managed by the Centers for Disease Control and Prevention (CDC).
Dr. Willy Burgdorfer: One Tick at a Time
Dr. Willy Burgdorfer, born on June 27, 1925, in Basel, Switzerland, is known for transforming the understanding of tick-borne illnesses.
Burgdorfer pursued his undergraduate and doctoral studies in parasitology and tropical bacteriology at the University of Basel – where he first developed his fascination with ticks while studying how these arthropods transmitted spirochetes that caused relapsing fever. In 1951, Burgdorfer moved to the United States for a fellowship in Montana at the Rocky Mountain Laboratories (RML) – a National Institute of Health biomedical research facility for vector-borne diseases, such as Rocky Mountain spotted fever, Lyme disease and Q fever.